Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

624
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
624
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

860
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
860

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptomic Insights Into Peppermint Adventitious Root Development Induced by Trichoderma Volatile Organic Compounds Under Salt Stress.

Physiologia plantarum·2026
Same author

Molecular breeding alters mycelium material properties in the white-rot fungus Pleurotus ostreatus.

Applied microbiology and biotechnology·2026
Same author

Isoreticular metal-organic framework-3 as a carrier of quantum dots for fluorescent immunolabeling in ultrasensitive lateral flow immunoassay of interleukin-6.

Analytical and bioanalytical chemistry·2025
Same author

Co-Inoculating <i>Burkholderia vietnamiensis</i> B418 and <i>Trichoderma harzianum</i> T11W Reduced <i>Meloidogyne incognita</i> Infestation of Tomato Plants.

Microorganisms·2025
Same author

MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson's disease.

Science translational medicine·2025
Same author

Colorimetric-fluorescent dual-mode background fluorescence-quenching lateral flow immunoassay: Principle, modeling, and application to folic acid detection.

Talanta·2025

Related Experiment Video

Updated: Nov 17, 2025

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.3K

Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles.

Yuanzheng Wu1, Jishun Li1, Hyun-Jae Shin2

  • 1Ecology Institute, Qilu University of Technology (Shandong Academy of Sciences), Shandong Provincial Key Laboratory of Applied Microbiology, Jinan, 250103 China.

Biotechnology and Bioprocess Engineering : BBE
|February 15, 2021
PubMed
Summary

Viral nanoparticles (VNPs) offer biocompatible, biodegradable drug delivery systems. These programmable scaffolds show promise as targeted anticancer vehicles due to their unique architectures and versatile modification capabilities.

Keywords:
anticancerdrug deliverynanotechnologyself-assemblyviral nanoparticles (VNPs)

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.8K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.8K

Related Experiment Videos

Last Updated: Nov 17, 2025

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.3K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.8K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.8K

Area of Science:

  • Nanotechnology
  • Biotechnology
  • Materials Science

Background:

  • Viral nanoparticles (VNPs) are versatile biological building blocks.
  • Their dynamic, symmetrical architectures are ideal for nanotechnology applications.
  • VNPs offer advantages like biocompatibility and biodegradability over synthetic nanoparticles.

Purpose of the Study:

  • To summarize recent advancements in viral nanoparticles (VNPs).
  • To highlight VNPs as targeted anticancer delivery vehicles.
  • To explore VNP encapsulation, surface modification, and application potential.

Main Methods:

  • Review of current literature on viral nanoparticles.
  • Analysis of VNP encapsulation and surface modification strategies.
  • Evaluation of VNP applications in targeted cancer therapy.

Main Results:

  • VNPs serve as programmable scaffolds for targeted moiety display and payload encapsulation.
  • VNP-based drug delivery systems exhibit superior biocompatibility, biodegradability, and uptake.
  • VNPs show significant potential as targeted anticancer agents.

Conclusions:

  • Viral nanoparticles represent a promising platform for advanced drug delivery systems.
  • Further research into VNP mechanisms can optimize their use in cancer therapy.
  • VNPs offer a sustainable and effective alternative to synthetic nanoparticles in nanomedicine.